Sponsor content
70 result(s) found, displaying 51 to 60
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for YUFLYMA adalimumab (rch) 40 mg/0.4 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for YUFLYMA adalimumab (rch) 40 mg/0.4 mL solution for injection pre-filled syringe with a safety guard.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for YUFLYMA adalimumab (rch) 40 mg/0.4 mL solution for injection pre-filled syringe in autoinjector.
-
Australian public assessment report (AusPar)AusPAR for Yuflyma (adalimumab) for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis and psoriatic arthritis etc.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Celltrion Healthcare Australia Pty Ltd - Skin-cleaning wipe, sterile.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Celltrion Healthcare Australia Pty Ltd - Antiseptic swab.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REMSIMA infliximab 120 mg solution for injection prefilled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REMSIMA infliximab 120 mg solution for injection prefilled syringe with safety guard.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REMSIMA infliximab 120 mg solution for injection prefilled syringe in auto-injector pen.
-
Prescription medicine decision summaryTGA Decision: Yuflyma (adalimumab) is approved to treat multiple auto-immune conditions.